Arief Pramuhanto - Kimia Farma Human Capital and General Affairs Director
KAEF Stock | IDR 635.00 5.00 0.78% |
Director
Mr. Arief Pramuhanto serves as Human Capital and General Affairs Director of PT Kimia Farma Tbk since April 20, 2017. He obtained Bachelor in Construction Management from Institut Teknologi Bandung and MBA from Monash University, Australia . He also serves as Human Capital Group Head at PT Bank BTN since 2015. He was GMHuman Resource Development at PT Frisian Flag, Training and Development Manager at PT Thames Pam Jaya, Change Management Staff at Standard Chartered Bank, Loan Officer at BAPINDO and Assistant EngineerChange Management at Andersen Consultants . since 2017.
Age | 56 |
Tenure | 7 years |
Professional Marks | MBA |
Phone | 62 21 384 7709 |
Web | https://kimiafarma.co.id |
Kimia Farma Management Efficiency
Kimia Farma's management efficiency ratios could be used to measure how well Kimia Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 5 records | DIRECTOR Age | ||
Pundjung Brata | Adhi Karya Persero | 58 | |
Vidjongtius | Kalbe Farma Tbk | 59 | |
Entus Mukhson | Adhi Karya Persero | 61 | |
Agus Karianto | Adhi Karya Persero | 55 | |
Subakti Syukur | Jasa Marga Tbk | 60 |
Management Performance
Return On Equity | -0.026 | |||
Return On Asset | 0.0089 |
Kimia Farma Persero Leadership Team
Elected by the shareholders, the Kimia Farma's board of directors comprises two types of representatives: Kimia Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kimia. The board's role is to monitor Kimia Farma's management team and ensure that shareholders' interests are well served. Kimia Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kimia Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pujianto, Business Development Director | ||
David Utama, Pres Director | ||
I Wijaya, Finance Director | ||
Jasmine Karsono, RD Marketing | ||
Nurrachman, Independent Commissioner | ||
CIA CPIA, Head Audit | ||
Arief Pramuhanto, Human Capital and General Affairs Director | ||
Honesti Basyir, President Director | ||
Ganti Putro, Corporate Secretary | ||
Dharma MM, HR Director | ||
Verdi Budidarmo, Production and Supply Chain Director | ||
Lina MM, F Director | ||
MM Apt, Director Director | ||
Untung Sutarjo, President Commissioner | ||
Wahono Sumaryono, Independent Commissioner | ||
Chrisma Albandjar, Commissioner | ||
Eva Fairus, Gen Sales | ||
Muhammad Fauzi, Commissioner | ||
Rosrini, Compliance Mang |
Kimia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kimia Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.026 | |||
Return On Asset | 0.0089 | |||
Profit Margin | (0.02) % | |||
Operating Margin | 0.03 % | |||
Current Valuation | 14.62 T | |||
Shares Outstanding | 5.55 B | |||
Shares Owned By Insiders | 95.80 % | |||
Shares Owned By Institutions | 0.07 % | |||
Price To Book | 0.90 X | |||
Price To Sales | 0.60 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.